CA2633515C - Compositions et procedes pour le traitement dermique de la douleur - Google Patents

Compositions et procedes pour le traitement dermique de la douleur Download PDF

Info

Publication number
CA2633515C
CA2633515C CA2633515A CA2633515A CA2633515C CA 2633515 C CA2633515 C CA 2633515C CA 2633515 A CA2633515 A CA 2633515A CA 2633515 A CA2633515 A CA 2633515A CA 2633515 C CA2633515 C CA 2633515C
Authority
CA
Canada
Prior art keywords
formulation
volatile solvent
pain
drug
solvent system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2633515A
Other languages
English (en)
Other versions
CA2633515A1 (fr
Inventor
Jie Zhang
Sanjay Sharma
Kevin S. Warner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvo Research Inc
Original Assignee
ZARS Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZARS Pharma Inc filed Critical ZARS Pharma Inc
Priority to CA2747845A priority Critical patent/CA2747845C/fr
Publication of CA2633515A1 publication Critical patent/CA2633515A1/fr
Application granted granted Critical
Publication of CA2633515C publication Critical patent/CA2633515C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
CA2633515A 2005-12-14 2006-12-14 Compositions et procedes pour le traitement dermique de la douleur Expired - Fee Related CA2633515C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2747845A CA2747845C (fr) 2005-12-14 2006-12-14 Compositions et procedes pour le traitement dermique de la douleur

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US75068305P 2005-12-14 2005-12-14
US75063705P 2005-12-14 2005-12-14
US75051905P 2005-12-14 2005-12-14
US60/750,519 2005-12-14
US60/750,683 2005-12-14
US60/750,637 2005-12-14
PCT/US2006/047926 WO2007070679A2 (fr) 2005-12-14 2006-12-14 Compositions et procedes pour le traitement dermique de la douleur

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2747845A Division CA2747845C (fr) 2005-12-14 2006-12-14 Compositions et procedes pour le traitement dermique de la douleur

Publications (2)

Publication Number Publication Date
CA2633515A1 CA2633515A1 (fr) 2007-06-21
CA2633515C true CA2633515C (fr) 2011-10-18

Family

ID=38163542

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2633515A Expired - Fee Related CA2633515C (fr) 2005-12-14 2006-12-14 Compositions et procedes pour le traitement dermique de la douleur

Country Status (5)

Country Link
EP (1) EP1959931A4 (fr)
JP (1) JP2009524586A (fr)
AU (1) AU2006326018B2 (fr)
CA (1) CA2633515C (fr)
WO (1) WO2007070679A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
WO2008089242A1 (fr) 2007-01-16 2008-07-24 Dermworx, Incorporated Anesthésique topique pour anesthésie locale rapide et méthode d'application d'un anesthésique topique
US9283177B2 (en) 2007-01-16 2016-03-15 Juventio, Llc Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
EP2252608A4 (fr) 2008-02-29 2012-10-03 Vm Discovery Inc Procédé de traitement du syndrome de la douleur et d'autres troubles
WO2010008600A1 (fr) * 2008-07-16 2010-01-21 Dermworx Incorporated Système d'apport de médicament topique
US9012477B2 (en) * 2009-01-06 2015-04-21 Nuvo Research Inc. Method of treating neuropathic pain
WO2010114973A1 (fr) * 2009-04-01 2010-10-07 Jie Zhang Méthodes de traitement des douleurs myofasciales, musculaires et/ou dorsales
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
MX2011011698A (es) 2009-05-04 2012-02-29 Zars Pharma Inc Metodo para tratar dolores asociados con neuroma, entrapamiento nervioso y otras condiciones.
BR112012017554B8 (pt) 2010-01-14 2021-05-25 Crescita Therapeutics Inc formulações de anestésicas locais formadoras de sólido para controle da dor
US20130324502A1 (en) 2011-02-10 2013-12-05 Moberg Pharma Ab Novel formulations for dermal, transdermal and mucosal use 1
EP3569227A1 (fr) * 2011-05-10 2019-11-20 Itochu Chemical Frontier Corporation Timbre non aqueux
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
US9925264B2 (en) 2011-05-10 2018-03-27 Itochu Chemical Frontier Corporation Non-aqueous patch
JP2014515365A (ja) * 2011-05-26 2014-06-30 ノバルティス アーゲー 生理学的活性剤の経皮投与のための組成物
CN102302418B (zh) * 2011-09-21 2013-01-23 韩褆 节水型多功能洗手消毒液
DK2823815T3 (en) * 2011-09-27 2018-08-06 Itochu Chemical Frontier Corp NON-DIFFICULT PLASTER
CN103142458B (zh) * 2013-01-22 2015-09-09 莱普德制药有限公司 无成瘾性镇痛缓释递药系统的组方与制备方法
GB201317718D0 (en) * 2013-10-07 2013-11-20 Buzzz Pharmaceuticals Ltd Novel formulation
JP6209749B2 (ja) * 2015-12-10 2017-10-11 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤
US11141387B2 (en) 2017-01-05 2021-10-12 Medrx Co., Ltd. Memantine-containing transdermally absorbable liquid
AU2018378072A1 (en) 2017-12-04 2020-05-21 Johnson & Johnson Consumer Inc. Topical emulsion composition containing nonsteroidal anti-inflammatory drug
WO2022167359A1 (fr) * 2021-02-02 2022-08-11 DuPont Nutrition USA, Inc. Composition de gel aqueux comprenant une éthylcellulose

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
EP1021204B1 (fr) * 1997-09-26 2005-12-28 Noven Pharmaceuticals, Inc. Compositions bioadhesives et methodes d'administration locale d'agents actifs
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6528086B2 (en) * 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
AUPQ419099A0 (en) * 1999-11-23 1999-12-16 Ko, Thomas Sai Ying Novel compositions and methods
US6432415B1 (en) * 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces

Also Published As

Publication number Publication date
AU2006326018B2 (en) 2013-04-18
EP1959931A4 (fr) 2012-08-22
AU2006326018A1 (en) 2007-06-21
WO2007070679A2 (fr) 2007-06-21
CA2633515A1 (fr) 2007-06-21
EP1959931A2 (fr) 2008-08-27
JP2009524586A (ja) 2009-07-02
WO2007070679A3 (fr) 2009-01-08

Similar Documents

Publication Publication Date Title
CA2633515C (fr) Compositions et procedes pour le traitement dermique de la douleur
US8741332B2 (en) Compositions and methods for dermally treating neuropathic pain
US20070189978A1 (en) Compositions and methods for dermally treating musculoskeletal pain
US8741333B2 (en) Compositions and methods for treating dermatitis or psoriasis
US20080019927A1 (en) Compositions and methods for dermally treating neuropathy with minoxidil
US20070190124A1 (en) Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
CA2633489C (fr) Compositions et procedes pour le traitement de conditions dermatologiques
CA2747845C (fr) Compositions et procedes pour le traitement dermique de la douleur
US20070196453A1 (en) Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20120294926A1 (en) Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070196452A1 (en) Flux-enabling compositions and methods for dermal delivery of drugs
US20070189977A1 (en) Spray-on formulations and methods for dermal delivery of drugs
US20070196293A1 (en) Compositions and methods for treating photo damaged skin
US20070196325A1 (en) Compositions and methods for dermally treating infections
US20070196323A1 (en) Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
US20070189980A1 (en) Compositions and methods for treating alopecia
EP1959930A2 (fr) Compositions de fluidification et procede pour administrer par voie cutanee des medicaments
WO2007070694A2 (fr) Formulations pouvant etre pulverisees et procedes pour administrer par voie cutanee des medicaments
CA2633464A1 (fr) Compositions et procedes d'administration dermique de medicaments

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20161214